BioLife Solutions Inc. (BLFS) Stock Price

BLFSStock

$38.61+45.20%52W

Market Cap$1.89B

P/E—

PEG Ratio15.09

Div yield—

Beta1.73

BLFS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)83.22%

Price vs S&P 500 (4W)7.97%

PEG Ratio15.09

VGM Score53.49

P/CF (Annual)93.91x

Book Value / Share (Quarterly)$8.59

P/TBV (Annual)3.17x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-15.91%

Cash Flow / Share (Quarterly)$0.15

Price vs S&P 500 (YTD)46.05%

Gross Margin (TTM)63.88%

Net Profit Margin (TTM)56.39%

EPS (TTM)$1.18

10-Day Avg Trading Volume1.51M

EPS Excl Extra (TTM)$1.18

Revenue Growth (5Y)14.87%

EPS (Annual)$-0.10

ROI (Annual)-1.22%

Gross Margin (Annual)64.56%

Net Profit Margin (5Y Avg)-34.13%

Cash / Share (Quarterly)$1.69

P/E Basic Excl Extra (TTM)32.58x

Revenue Growth QoQ (YoY)11.98%

ROA (Last FY)-1.13%

Revenue Growth TTM (YoY)34.39%

EBITD / Share (TTM)$0.09

ROE (5Y Avg)-13.48%

Operating Margin (TTM)2.90%

Cash Flow / Share (Annual)$-0.01

P/B Ratio4.50x

P/B Ratio (Quarterly)3.29x

Net Income / Employee (Annual)$-29,600

EV / Revenue (TTM)18.14x

Net Interest Coverage (TTM)-0.82x

ROA (TTM)14.09%

EPS Growth QoQ (YoY)-13.93%

EV / EBITDA (TTM)445.84x

EPS Incl Extra (Annual)$-0.10

Current Ratio (Annual)5.94x

Quick Ratio (Quarterly)6.67x

3-Month Avg Trading Volume1.11M

52-Week Price Return45.20%

EV / Free Cash Flow (Annual)403.10x

P/E Incl Extra (TTM)32.58x

Revenue / Employee (TTM)$663,300

Tangible BV / Share (Quarterly)$8.52

P/S Ratio (Annual)19.63x

Asset Turnover (Annual)0.24x

52-Week High$39.76

Operating Margin (5Y Avg)-29.03%

EPS Excl Extra (Annual)$-0.10

CapEx CAGR (5Y)21.39%

Tangible BV CAGR (5Y)16.11%

26-Week Price Return102.36%

Quick Ratio (Annual)4.22x

13-Week Price Return38.93%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)9.69x

Enterprise Value$1.86B

Revenue / Share Growth (5Y)2.72%

Asset Turnover (TTM)0.25x

Book Value / Share Growth (5Y)4.41%

Revenue / Employee (Annual)$620,700

Inventory Turnover (Annual)1.15x

Pretax Margin (Annual)-12.56%

Cash / Share (Annual)$1.84

3-Month Return Std Dev35.19%

Gross Margin (5Y Avg)43.72%

Net Income / Employee (TTM)$374,100

ROE (Last FY)-1.24%

Net Interest Coverage (Annual)-3.91x

EPS Basic Excl Extra (Annual)$-0.10

P/FCF (TTM)231.17x

Receivables Turnover (TTM)9.93x

EV / Free Cash Flow (TTM)248.23x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$1.18

Receivables Turnover (Annual)11.24x

ROI (TTM)15.13%

P/S Ratio (TTM)18.37x

Pretax Margin (5Y Avg)-29.13%

Revenue / Share (Annual)$2.01

Tangible BV / Share (Annual)$7.63

Forward P/E90.14x

Price vs S&P 500 (52W)29.42%

P/E Ratio (TTM)32.58x

Year-to-Date Return59.68%

5-Day Price Return-1.56%

EPS Normalized (Annual)$-0.10

ROA (5Y Avg)-11.06%

Net Profit Margin (Annual)-4.78%

Month-to-Date Return-0.62%

Cash Flow / Share (TTM)$-2.09

EBITD / Share (Annual)$-0.34

Operating Margin (Annual)-17.26%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)111.92x

ROI (5Y Avg)-12.62%

P/E Excl Extra (TTM)32.58x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$1.18

P/TBV (Quarterly)3.31x

P/B Ratio (Annual)3.13x

Inventory Turnover (TTM)1.17x

Pretax Margin (TTM)7.84%

Book Value / Share (Annual)$7.72

Price vs S&P 500 (13W)35.80%

Beta1.73x

P/FCF (Annual)666.05x

Revenue / Share (TTM)$2.09

ROE (TTM)15.28%

52-Week Low$17.86

vGradeF

gGradeC

mGradeA

vgmGradeC

BLFS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$0.06	$0.08	+40.50%(+$0.02)
Q1 2026	May 7, 2026	$0.02	$0.04	+160.95%(+$0.03)
Q4 2025	Feb 26, 2026	$0.01	$0.04	+680.00%(+$0.03)
Q3 2025	Nov 6, 2025	$0.00	$0.04	+1997.50%(+$0.04)
Q2 2025	Aug 7, 2025	-$0.01	$0.01	+220.00%(+$0.02)

BLFS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.19

4.20

3.60

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
BLFSBioLife Solutions Inc.	F	C	A	18.4x	14.9%	63.9%	2.9%	$38.61
MDTMedtronic plc	B	C	B	3.2x	3.8%	65.7%	18.1%	$94.75
ITGRInteger Holdings Corporation	C	C	A	2.3x	11.6%	26.1%	9.7%	$126.70
LIVNLivaNova PLC Ordinary Shares	C	B	B	2.9x	8.2%	68.1%	12.5%	$77.58
TMDXTransMedics Group, Inc. Common Stock	C	B	D	3.7x	88.2%	58.7%	12.2%	$70.78
AXGNAxogen, Inc. Common Stock	F	B	B	8.1x	14.9%	74.6%	-11.8%	$34.62
CNMDCONMED Corporation	B	C	B	1.0x	9.8%	55.8%	8.0%	$46.72
CBLLCeriBell, Inc. Common Stock	F	A	A	9.4x	—	88.9%	-68.6%	$25.04
INMDInMode Ltd. Ordinary Shares	A	D	C	2.2x	12.4%	76.5%	18.5%	$14.16
CVCapsoVision, Inc. Common Stock	F	D	B	25.0x	—	50.9%	-217.1%	$6.53
ELMDElectromed, Inc.	C	B	C	3.1x	15.6%	78.5%	18.8%	$27.42
FOCLEDAP TMS S.A. American Depositary Shares	C	C	D	2.3x	9.4%	47.6%	-40.7%	$4.09
STXSStereotaxis, Inc. Common Stock	D	F	D	3.4x	4.0%	55.6%	-75.7%	$1.01
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	29.9x	—	36.4%	-1004.7%	$1.12
NRXSNeuraxis, Inc.	F	A	A	18.2x	13.1%	85.5%	-144.5%	$7.70
STEXStreamex Corp. Common Stock	—	C	F	298.3x	—	100.0%	-10384.3%	$0.37
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	4.8x	115.2%	51.4%	-203.3%	$0.75
OMOutset Medical, Inc. Common Stock	A	C	C	0.6x	19.1%	41.8%	-56.1%	$3.94
ECORelectroCore, Inc. Common Stock	C	A	B	1.9x	55.7%	87.5%	-37.6%	$7.85
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	1.5x	24.2%	17.2%	-11.1%	$4.32
QTIQT Imaging Holdings, Inc. Common Stock	C	A	D	1.3x	—	40.4%	-56.2%	$2.40
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	50.5x	—	60.9%	-1776.4%	$3.84
IRIXIridex Corp	B	D	D	0.3x	7.7%	35.9%	-5.4%	$0.81
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	19.2x	—	51.4%	-1921.6%	$4.74
NXLNexalin Technology, Inc. Common Stock	D	D	F	11.3x	4.4%	86.2%	-4202.4%	$2.35
NUWENuwellis, Inc. Common Stock	—	D	F	0.2x	2.1%	69.7%	-142.9%	$0.55
EDAPEDAP TMS SA	D	C	C	2.2x	9.4%	46.6%	-37.3%	$3.99
EYESCorgi Data & Surveillance ETF	—	C	C	—	—	—	—	$28.78
FONRFonar Corporation	B	D	B	1.3x	4.0%	40.3%	9.1%	$0.00
MASIMasimo Corporation	D	D	B	6.0x	6.0%	61.7%	19.9%	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	—	—	—	—	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	8.4x	13.2%	-58.1%	-1549.0%	$2.49

About BioLife Solutions Inc.

BioLife Solutions provides bioproduction solutions for the cell and gene therapy industry, including cell processing, cold chain, and thawing technologies designed to optimize manufacturing efficiency. The company's primary revenue driver is CryoStor, a biopreservation product for cell processing applications. The vast majority of revenue is generated in the United States market.

BLFS Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate$0.07

Revenue estimate$29.32M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

UFPTUFP Technologies IncSurgical & Medical Instruments
INSPInspire Medical Systems, Inc.Surgical & Medical Instruments
AEHRAehr Test SystemsInstruments for Measuring
BFLYButterfly Network, Inc.X-Ray Equipment
LMATLeMaitre Vascular, Inc.Surgical & Medical Instruments
ESTAEstablishment Labs Holdings Inc.Orthopedic & Prosthetic Devices
ALMRAlamar Biosciences, Inc. Common StockLab Analytical Instruments
LUNRIntuitive Machines, Inc. Class A Common StockDefense Systems & Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

3.6

Buy

Consensus rating

52-Week Range

Low$17.86

High$39.76